|
|
| Issue Open | Jan 31, 2020 |
| Issue Close | Feb 6, 2020 |
| IPO Price | ₹51 |
| Face Value | ₹10 |
| IPO Size | ₹10.20 Cr |
| Listing At | BSE SME |
| IPO Lot Size | 2000 |
Tue, 24 Aug 2021 16:53:00 GMT
This marks the beginning of CBC's journey into the global medical aesthetics sector, in addition to our current pharma, medtech and services exposure. By leveraging our foothold in international ...
Wed, 25 Aug 2021 01:11:00 GMT
(Bloomberg) --South Korean cosmetic pharmaceutical company Hugel Inc. said its largest investor, Bain Capital, has signed a deal to sell a 46.9% stake to a consortium led by private equity firm CBC ...
Thu, 02 Sep 2021 01:28:00 GMT
Also Read: Explained: Is the euphoria around IPOs fading? Glenmark Life Sciences, a wholly-owned subsidiary of Glenmark Pharmaceuticals, is a manufacturer of active pharmaceutical ingredients ...
Wed, 25 Aug 2021 02:38:00 GMT
South Korean cosmetic pharmaceutical company Hugel said its largest investor, Bain Capital, has signed a deal to sell a 46.9 per cent stake to a consortium led by private equity firm CBC Group.
Wed, 25 Aug 2021 12:23:00 GMT
Aerpio Pharmaceuticals (Nasdaq ... Aerpio, which launched a $42 million IPO in 2018, was one of Greater Cincinnati’s better-performing public companies of 2020, as investors poured more into ...
Mon, 13 Sep 2021 16:46:00 GMT
The founders say that to complete its mission to bring new, innovative drugs to the market, it is open to many different paths — be that through an IPO or SPAC deal or a merger. And it’s not just the ...
Mon, 13 Sep 2021 04:40:00 GMT
13, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. ("InMed" or the "Company ... BayMedica's initial rare cannabinoid product, Prodiol® CBC (cannabichromene), have grown steadily since ...
Tue, 03 Aug 2021 05:51:00 GMT
Bausch said in March it would sell its entire stake in Egypt's Amoun Pharmaceutical Co SAE and last year announced plans to spin off Bausch + Lomb. Solta's IPO will now create three companies ...
Tue, 24 Aug 2021 17:21:00 GMT
joining an industry-leading portfolio in the pharmaceuticals and biotech, medical technology and service sectors. Founded in 2014, CBC has consistently focused on control-oriented acquisitions and ...
Tue, 24 Aug 2021 23:10:00 GMT
As CBC continues to build its presence in the Asian healthcare sector, this transaction marks its strategic entrance into the medical aesthetics sector, joining an industry-leading portfolio in the ...
The IPO Shares of Chandra Bhagat Pharma Ltd IPO are proposed to list on Friday, February 14, 2020 at BSE SME. The public issue of CBC Pharma IPO was opened on Jan 31, 2020 and closed for subscription on Feb 6, 2020. CBC Pharma IPO Listing Date and Information:
| Listing Date | Friday, February 14, 2020 |
| BSE Script Code | 542934 |
| NSE Symbol | |
| Listing In | |
| ISIN | INE07QQ01016 |
| Issue Price | Rs 51 Per Equity Share |
| Face Value | Rs 10 Per Equity Share |
The allotment status of Chandra Bhagat Pharma Ltd IPO is now available online. The public issue of CBC Pharma IPO was open on Jan 31, 2020 and closed for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME.
Chandra Bhagat Pharma Ltd is entering in the capital market with an IPO of 2,000,000 Equity Shares of Rs 10 aggregating up to Rs 10.20 Crore. The price for the issue has been set at Rs 51 Per Equity Share.
Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.
The issue opens on Jan 31, 2020 and closes for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME.
The issue of Chandra Bhagat Pharma Ltd opens on Jan 31, 2020 and closes for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.
The CBC Pharma IPO is proposed to open on Jan 31, 2020. The IPO application ends on Feb 6, 2020.
Retail investors can apply in the retail or non-institutional investor category from Jan 31, 2020 to Feb 6, 2020. The CBC Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The CBC Pharma IPO will open for subscription on Jan 31, 2020. The public issue will close on Feb 6, 2020.
Useful Articles
Rs 0 Eq Delivery Brokerage
Flat ₹10 Per Trade in F&O
Rs 0 Demat AMC
